(19)
(11) EP 1 546 132 A1

(12)

(43) Date of publication:
29.06.2005 Bulletin 2005/26

(21) Application number: 03798326.9

(22) Date of filing: 15.09.2003
(51) International Patent Classification (IPC)7C07D 401/12, A61K 31/415, A61K 31/4155, C07D 231/28, C07D 403/12, C07D 417/12, A61P 31/18
(86) International application number:
PCT/IB2003/004158
(87) International publication number:
WO 2004/029042 (08.04.2004 Gazette 2004/15)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 26.09.2002 GB 0222374
08.10.2002 GB 0223356

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • Barba, Oscar
    Sandwich, Kent, CT13 9NJ (GB)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LU MC NL PT 

(72) Inventors:
  • BARBA, OscarPfizer Global Research & Development
    SandwichKent, CT13 9NJ (GB)
  • JONES, L. H.Pfizer Global Research & Development
    SandwichKent CT13 9NJ (GB)

(74) Representative: Nevant, Marc et al
Cabinet Beau de Loménie,158, rue de l'Université
75007 Paris Cedex 07
75007 Paris Cedex 07 (FR)

   


(54) PYRAZOLE DERIVATIVES AS REVERSE TRANSCRIPTASE INHIBITORS